The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction

Post time 1 hour(s) ago

journal：The Journal of Heart and Lung Transplantation

Authors：Daniel C. Chambers; Glen Westall; David Darley; Michael Musk; Allan R. Glanville; Monique Malouf; Chien-Li Holmes-Liew; Maxine Tan; Simon H. Apte; Penelope L. Groves; Viviana P. Lutzky; Marian J. Sturm; Sharon Lawrence; Natalee Lawson; Lisa Singleton; Sjane Timmins; Debra Enever; Holly Wildermuth; Omega Daka; Brittany Cooper; Leslie Winks; Sharon Haines; Lai-Ying Zhang; Bronwyn Levvey; Yvonne Cristiano; Meow Yaw; Greg Snell; Michael Trotter; Alan Carew; Mark Holmes; Andreas Fiene; Chandima Divithotawela; Stephanie Yerkovich; John A. Mackintosh; Peter M.A. Hopkins

Published date：2026-8-

DOI：10.1016/j.healun.2026.03.032

PDF link：https://www.sciencedirect.com/sc ... 05324982601819X/pdf

Article link：https://doi.org/10.1016/j.healun.2026.03.032

Article Source：Elsevier BV。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction